Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Digital Proteomics

Digital Proteomics
Accelerator/Inc LATEST DEAL TYPE

Provider of a antibody discovery platform designed to make proteomic workflow more efficient. The company's antibody discovery platform utilizes mass spectrometry to deeply sample the antibodies present in serum and further employs sophisticated spectrum analysis algorithms to identify novel antibody clones that were missed by next-generation sequencing, increasing the serum repertoire diversity by as much as 50, enabling researchers to make antibody discovery more efficient in order to accelerate clinical development.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare
Discovery Tools (Healthcare)
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States

+1 (619) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Digital Proteomics’s full profile, request a free trial.

Digital Proteomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-May-2017 Completed Generating Revenue
1. Grant 16-Feb-2017 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Digital Proteomics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
JLABS Accelerator/Incubator 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Digital Proteomics Executive Team (3)

Name Title Board
Natalie Castellana Ph.D Chief Executive Officer & Chief Technology Officer
Stefano Bonissone Ph.D Chief Scientific Officer & Co-Chief Technology Officer
Anand Patel Co-Chief Technology Officer